Expanded Access Program for GBM Subjects
- Status
- AVAILABLE
- Phase
- N/A
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Artificial Intelligence-Guided Radiotherapy Planning for Glioblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
PET-imaging of Two Vartumabs in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Key Longitudinal Associations With Risk and Glioblastoma Outcomes
- Status
- RECRUITING
- Phase
- N/A
Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE4
Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques
- Status
- RECRUITING
- Phase
- NA
A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma
- Status
- COMPLETED
- Phase
- N/A
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE3
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)
- Status
- RECRUITING
- Phase
- NA
Targeted Survivin DC Cell Injection for the Treatment of GBM
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
- Status
- RECRUITING
- Phase
- NA
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
- Status
- RECRUITING
- Phase
- PHASE3
Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Expectations and Needs of a Glioblastoma Caregiver
- Status
- COMPLETED
- Phase
- N/A